glp-1 oral health news New weight loss drugs available GLP-1 Medications & Dental Health:

Haldar, S., Chia, S

Colebrook, L., Buttle, G

Citicoline for acute ischemic atroke: a systematic review and formal meta-analysis of randomized, double-blind, and placebo-controlled trials

Every telehealth platform offering compounded GLP-1 medications operates under the same regulatory framework

The research findings highlight the absence of a connection between clinical benefits and short-term cost savings, with the study authors concluding: "Our 24-month analysis did not demonstrate cost savings, in contrast to industry-sponsored models that project long-term savings (eg, over 10 years) based on trial-derived effectiveness. There have been fewer studies focused on the more recently approved tirzepatide-based drug Zepbound